NCT03259646

Brief Summary

Violence against women is a major public health threat that carries significant consequences for women's health. Moreover, women experiencing intimate partner violence (IPV) and sexual assault (SA) are more likely than non-abused women to seek certain forms of health services, such as for sexually transmitted infections, chronic pain and illnesses, depression and/or pregnancy-related concerns. As a result, the health sector is an ideal setting to identify and support survivors. The U.S. Institute of Medicine has identified the health care system, including the public health infrastructure, as key for identification of and support for survivors of violence, as well as for violence prevention. While some evidence-based models exist, no current national consensus has been reached on scalable best practices in screening and brief counseling for IPV/SA. This multi-level intervention includes integrating into the clinic setting IPV/SA screening, universal education, trauma informed counseling, warm referrals (e.g. provider/staff contact advocacy program with survivor) to local IPV/SA advocacy agencies, and access to the evidence-based myPlan safety decision aid app. The evaluation, using a cluster randomized trial design, will measure longitudinal outcomes (over 6 months) of patient self-efficacy, health and safety outcomes, as well as participant and provider perceptions of the intervention and clinic level changes in primary and reproductive health clinics in four states (Arizona, Massachusetts, Pennsylvania and West Virginia) to achieve the following aims: Aim 1. Evaluate the effectiveness of an evidence-based screening, universal education and trauma-informed counseling with tailored safety action plan and referrals to partner IPV/SA programs compared to standard practice, on survivor health and safety outcomes over a cumulative period of six months. Aim 2. Examine longitudinal changes in clinic-level screening, universal education, trauma informed counseling, safety action plans and referrals to on-site and/or partner IPV/SA programs and improved standards for documentation through the electronic health record (EHR) and continuous quality measurement and reporting.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6,272

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2017

Typical duration for not_applicable

Geographic Reach
1 country

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 26, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 21, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 24, 2017

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 25, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 25, 2019

Completed
Last Updated

January 18, 2020

Status Verified

January 1, 2020

Enrollment Period

1.9 years

First QC Date

August 21, 2017

Last Update Submit

January 16, 2020

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in use of safety behaviors

    Measured by percent of safety behaviors the woman has tried and found helpful on the Safety Behaviors Checklist. The checklist was adapted from Sullivan and colleagues and Parker and colleagues. Includes use of community resources and safety steps (e.g. asked for help, hidden emergency money) and use of formal services (e.g., women's shelter, protection order, mental health services).

    6 months

  • Change in Self-Efficacy to Use Harm Reduction Strategies

    Measure adapted from Tancredi et al and Hibbard et al, assesses confidence to seek help for abuse, if needed, from a health care provider.

    6 months

  • Provider Behavior

    Clinic level measure. Provider Behavior at Visit Survey items administered after the provider visit to assess the provider's adherence to universal education intervention, i.e. discussing healthy and unhealthy relationships during the visit, and referring to resources.

    Baseline

Secondary Outcomes (2)

  • Change in decisional conflict

    6 months

  • Change in Readiness to Take Action

    6 months

Study Arms (2)

Universal Education

EXPERIMENTAL

Train providers to integrate screening, universal education, trauma informed counseling, and mobile health (mHealth) technology through the myPlan app safety decision aid in collaboration with local IPV programs as well as the integration of documentation and quality improvement templates and measures into clinical settings.

Behavioral: Universal Education

Standard Practice

NO INTERVENTION

Standard clinical practice

Interventions

Clinic provider/staff training on implementing universal education into clinical practice to: 1.) provide all women information about IPV/SA, harm reduction, and available safety resources; 2) provide trauma-informed counseling to women who disclose IPV/SA; includes access to the myPlan safety decision aid to develop a tailored safety action plan; 3) provide warm referrals in partnership with local domestic violence and sexual assault (DV/SA) advocacy agencies; 4) integrate documentation and quality improvement templates and measures into clinical settings.

Universal Education

Eligibility Criteria

Age18 Years - 59 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsCis-gender or trans-gender women.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Seeking healthcare at one of 14 partner clinics
  • Ability to complete a survey on a device (computer/tablet/smartphone in English or Spanish)
  • Access to safe device (as defined above) if doing surveys online
  • Has a safe email address or safe phone number
  • Is not acutely ill

You may not qualify if:

  • Male
  • Not seeking healthcare at one of 9 partner clinics
  • Younger than 18 years of age
  • Older than 59 years of age
  • Cannot read/speak English or Spanish
  • No access to safe device if doing surveys online
  • Does not have a safe email address or safe phone number
  • Acutely ill

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

North County HealthCare

Kingman, Arizona, 86401, United States

Location

North Country HealthCare

Lake Havasu City, Arizona, 86403, United States

Location

North Country HealthCare

Williams, Arizona, 86046, United States

Location

Partners Health Care Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location

Magee-Women's Hospital of UPMC

Pittsburgh, Pennsylvania, 15213, United States

Location

Women's Health Center

Charleston, West Virginia, 25302, United States

Location

Valley Health

Mill Creek, West Virginia, 26280, United States

Location

Greenbrier Co. Health Dept

Ronceverte, West Virginia, 24970, United States

Location

FamilyCare Health Center

Scott Depot, West Virginia, 25560, United States

Location

MeSH Terms

Conditions

Coitus

Condition Hierarchy (Ancestors)

Sexual BehaviorBehavior

Study Officials

  • Nancy Glass, PhD, MPH, RN

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: cluster randomized trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 21, 2017

First Posted

August 24, 2017

Study Start

May 26, 2017

Primary Completion

April 25, 2019

Study Completion

April 25, 2019

Last Updated

January 18, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations